DOI QR코드

DOI QR Code

Studies on the Content of Lectin in Korean Mistletoe according to the Host Tree Species and Characterization for Its Application to the Quality Control

한국산 겨우살이 숙주별 렉틴 함량과 지표물질로서의 특성 조사

  • Received : 2015.11.06
  • Accepted : 2015.12.28
  • Published : 2015.12.31

Abstract

Traditionally, mistletoe is known as an effective anti-cancer medicinal plant, and lectin is recognized as a major component with cytotoxic and immuno-stimulant activity in mistletoe. A Korean mistletoe lectin (KML) has specificity to galactose and galactosamine and is distinguish from European mistletoe lectin (EML). When we examined the concentration of lectin in mistletoe originated from five different types of host trees, the result indicate that the lectin concentration is variable depending on the host tree. Noticeably, mistletoe from chestnut tree contains ten folds higher lectins than that of an oak tree. We also tested the concentration of KML and crude extract (KM-110) of Korean mistletoe that shows 90% cytotoxicity in L5178Y-ML25 lymphoma cell. In addition, the cells show 90% and 70% viability by the treatment of two neutralizing antibodies of KML, 9H7-D10 and 8B11-2C5 neutralization effect with two monoclonal antibodies of KML, 9H7-D10 and 8B11-2C5. Therefore, the result expected that the mistletoe contain some other cytotoxic components except lectin. Finally, the production of $TNF-{\alpha}$ and IL-6 by RAW 264.7 cells stimulated with lectin free-crude extract (LFKM-110) following neutralization by 9H7-D10 monoclonal antibody shows higher than that of lectin containing-crude extract (KM-110). These results suggest that the Korean mistletoe lectin ha a great potential to be developed as therapeutic agent of cancer.

겨우살이는 전통적으로 항암활성이 있는 약용식물의 하나로 알려져 왔고, 렉틴은 세포독성 및 면역자극 자극 활성을 가지는 대표성분으로 인정되고 있다. 한국산 겨우살이에 함유되는 렉틴은 유럽산의 그것과는 달리 galactose와 N-acetylgalactosamine(GalNAc) 특이성을 동시에 가지는 렉틴 성분인 KML인 것으로 나타났다. Sandwich ELISA법을 이용하여 각기 다른 종류의 숙주나무에서 유래된 5종의 겨우살이로부터 렉틴 함량을 비교한 결과, 숙주나무별 차이가 인정되어 밤나무 겨우살이는 참나무 겨우살이에 비하여 약 10배 많은 렉틴을 함유하고 있었다. L5178Y-ML25 lymphoma 세포에 약 90%의 세포독성을 나타내는 농도의 KML과 한국산 참나무 유래 겨우살이 추출물인 KM-100에 두 종류의 단일클론 항체(9H7-10 and 8B11-2C5)를 동시처리한 후 세포독성 중화효과를 조사한 결과, KML의 경우 약 10%, KM-110의 경우 약 30%의 세포독성을 보였다. 이러한 결과는 겨우살이에서 렉틴 외에도 세포독성을 가지는 다른 성분이 존재할 것으로 사료되었다. RAW 264.7 대식 세포주에 KM-110과 KM-110으로부터 렉틴이 제거된 분획인 LFKM-110을 자극시킨 결과, LFKM-110에서 $TNF-{\alpha}$ 및 IL-6와 같은 cytokine의 생산을 증진시키는 결과를 보였다. 따라서 KM-110에서 면역 세포를 자극하는 다른 성분의 존재하고 있음을 강하게 제시되었다.

Keywords

References

  1. Beuth J. 1997. Clinical relevance of immunoactive mistletoe lectin-I. Anticancer Drugs 8(Supple 1):S53-S55 https://doi.org/10.1097/00001813-199704001-00012
  2. Bocci V. 1993. Mistletoe (Viscum album) lectins as cytokine inducers and immunoadjuvant in tumor theapy. A review. J. Biol Regul Homeost Agents 7:1-6
  3. Choi OB. 2009. The importance of clinical mistletoe cancer therapy and Korean mistletoe pharmacopuncture preparation development and application possibility for oriental medicine. J Pharmacopuncture 12:77-89
  4. Franz H, Ziska P, Kindt A. 1981. Isolation and properties of three lectins from mistletoe (Viscum album L.). Biochem J 195:481-484 https://doi.org/10.1042/bj1950481
  5. Gabius S, Joshi SS, Kayser K, Gabius H. 1992. The galactosidespecific lectin from mistletoe as biological response modifier. Int J Oncol 1:705-708
  6. Hajto T, Fodor K, Perjesi P, Nemeth P. 2011. Difficulties and perspectives of immunomodulatory therapy with mistletoe lectins and standardized mistletoe extracts in evidence-based medicine. J Evidence-Based Complementary Altern Med 8:1-6
  7. Jaggy C, Musielski H, Urech K, Schaller G. 1995. Quantitative determination of lectins in mistletoe preparations. Arzneimittelforschung 45:905-909
  8. Kang SJ, Chung SK. 2012. Antioxidant and antimicrobial activities of Korean mistletoe (Viscum album var, coloratum) extracts against food poisoning bacteria. Korean J Food Preserv 19:919-924 https://doi.org/10.11002/kjfp.2012.19.6.919
  9. Kang TB, Song SK, Yoon TJ, Yoo YC, Lee KH, Her E, Kim JB. 2007. Isolation and characterization of two Korean mistletoe lectins. J Biochem Mol Biol 40:959-965 https://doi.org/10.5483/BMBRep.2007.40.6.959
  10. Kirsch A. 2007. Successful treatment of metastatic malignant melanoma with Viscum album extract (Iscador M). J Altern Complement Med 13:443-445 https://doi.org/10.1089/acm.2007.6175
  11. Kuttan G, Kuttan R. 1992. Immunomodulatory activity of a peptide isolated from Viscum album extract (NSC 635 089). Immunol Invest 21:285-296 https://doi.org/10.3109/08820139209069368
  12. Lee SJ, Lee MK, Choi GP, Yu CY, Roh SK, Kim JD, Lee HY, Lee JH. 2003. Growth enhancement and cytotoxicity of Korean mistletoe fractions on human cell lines. Korean J Medicinal Crop Sci 11:62-70
  13. Parhami-Seren B, Bell C, Margolies MN, Haupert GT Jr. 1999. Monoclonal antibodies that distinguish between two related digitalis glycosides, ouabain and digoxin. J Immunol 163:4360-4366
  14. Stein GM, Edlund U, Pfuller U, Bussing A, Schietzel M. 1999. Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro. Anticancer Res 19:3907-3914
  15. Stein GM, Schietzel M, Bussing A. 1998. Mistletoe in immunology and the clinic (short review). Anticancer Res 18:3247-3249
  16. Tabiasco J, Pont F, Fournie JJ, Vercellone A. 2002. Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity. Eur J Biochem 269:2591-2600 https://doi.org/10.1046/j.1432-1033.2002.02932.x
  17. Yoon TJ, Yoo YC, Kang TB, Kim SH, Kim KS, Kim JB. 2001. Production of monoclonal antobodies to Korean mistletoe lectin (KML-C) and their characterization. J Pharm Soc Korea Yakhak Hoeji 45:180-189
  18. Yoon TJ, Yoo YC, Kang TB, Song SK, Lee KB, Her E, Song KS Kim JB. 2003. Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells. Arch Pharm Res 26:861-867 https://doi.org/10.1007/BF02980033